330 related articles for article (PubMed ID: 15173061)
21. Beyond lipid-lowering: effects of statins on endothelial nitric oxide.
Laufs U
Eur J Clin Pharmacol; 2003 Mar; 58(11):719-31. PubMed ID: 12634978
[TBL] [Abstract][Full Text] [Related]
22. The pro- and antiangiogenic effects of statins.
Skaletz-Rorowski A; Kureishi Y; Shiojima I; Walsh K
Semin Vasc Med; 2004 Nov; 4(4):395-400. PubMed ID: 15861320
[TBL] [Abstract][Full Text] [Related]
23. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions.
Mason RP; Walter MF; Day CA; Jacob RF
Am J Cardiol; 2005 Sep; 96(5A):11F-23F. PubMed ID: 16126019
[TBL] [Abstract][Full Text] [Related]
24. Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction.
Ito MK; Talbert RL; Tsimikas S
Pharmacotherapy; 2006 Jul; 26(7 Pt 2):85S-97S; discussion 98S-101S; quiz 106S-108S. PubMed ID: 16803418
[TBL] [Abstract][Full Text] [Related]
25. Effect of statins on the proteasomal activity in mammalian endothelial and vascular smooth muscle cells.
Ludwig A; Friedel B; Metzkow S; Meiners S; Stangl V; Baumann G; Stangl K
Biochem Pharmacol; 2005 Aug; 70(4):520-6. PubMed ID: 15996638
[TBL] [Abstract][Full Text] [Related]
26. Statins: multiple mechanisms of action in the ischemic brain.
Cimino M; Gelosa P; Gianella A; Nobili E; Tremoli E; Sironi L
Neuroscientist; 2007 Jun; 13(3):208-13. PubMed ID: 17519364
[TBL] [Abstract][Full Text] [Related]
27. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.
Boodhwani M; Nakai Y; Voisine P; Feng J; Li J; Mieno S; Ramlawi B; Bianchi C; Laham R; Sellke FW
Circulation; 2006 Jul; 114(1 Suppl):I402-8. PubMed ID: 16820608
[TBL] [Abstract][Full Text] [Related]
28. Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway.
Ota H; Eto M; Kano MR; Kahyo T; Setou M; Ogawa S; Iijima K; Akishita M; Ouchi Y
Arterioscler Thromb Vasc Biol; 2010 Nov; 30(11):2205-11. PubMed ID: 20705918
[TBL] [Abstract][Full Text] [Related]
29. [The pleiotropic effects of statins].
Wolfovitz E
Harefuah; 2005 Aug; 144(8):577-82, 597. PubMed ID: 16146158
[TBL] [Abstract][Full Text] [Related]
30. [Arginine and statins: relationship between the nitric oxide pathway and the atherosclerosis development].
Rasmusen C; Cynober L; Couderc R
Ann Biol Clin (Paris); 2005; 63(5):443-55. PubMed ID: 16230278
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells.
Thum T; Fraccarollo D; Galuppo P; Tsikas D; Frantz S; Ertl G; Bauersachs J
Cardiovasc Res; 2006 Apr; 70(1):50-60. PubMed ID: 16480696
[TBL] [Abstract][Full Text] [Related]
32. Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?
Balakumar P; Kathuria S; Taneja G; Kalra S; Mahadevan N
J Mol Cell Cardiol; 2012 Jan; 52(1):83-92. PubMed ID: 21968328
[TBL] [Abstract][Full Text] [Related]
33. Blockade of geranylgeranylation by rosuvastatin upregulates eNOS expression in human venous endothelial cells.
Landsberger M; Jantzen F; Könemann S; Felix SB
Biochem Biophys Res Commun; 2005 Nov; 336(4):1005-9. PubMed ID: 16165089
[TBL] [Abstract][Full Text] [Related]
34. The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose.
Piconi L; Corgnali M; Da Ros R; Assaloni R; Piliego T; Ceriello A
J Diabetes Complications; 2008; 22(1):38-45. PubMed ID: 18191076
[TBL] [Abstract][Full Text] [Related]
35. Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells.
Sen-Banerjee S; Mir S; Lin Z; Hamik A; Atkins GB; Das H; Banerjee P; Kumar A; Jain MK
Circulation; 2005 Aug; 112(5):720-6. PubMed ID: 16043642
[TBL] [Abstract][Full Text] [Related]
36. Adverse balance of nitric oxide/peroxynitrite in the dysfunctional endothelium can be reversed by statins.
Heeba G; Hassan MK; Khalifa M; Malinski T
J Cardiovasc Pharmacol; 2007 Oct; 50(4):391-8. PubMed ID: 18049306
[TBL] [Abstract][Full Text] [Related]
37. The acute (cerebro)vascular effects of statins.
Prinz V; Endres M
Anesth Analg; 2009 Aug; 109(2):572-84. PubMed ID: 19608834
[TBL] [Abstract][Full Text] [Related]
38. Statins blunt thrombin-induced down-regulation of endothelial nitric oxide synthase expression in human endothelial cells.
Eto M; Rathgeb L; Cosentino F; Kozai T; Lüscher TF
J Cardiovasc Pharmacol; 2006 May; 47(5):663-7. PubMed ID: 16775505
[TBL] [Abstract][Full Text] [Related]
39. The role of fat tissue in the cholesterol lowering and the pleiotropic effects of statins--statins activate the generation of metabolically more capable adipocytes.
Erol A
Med Hypotheses; 2005; 64(1):69-73. PubMed ID: 15533614
[TBL] [Abstract][Full Text] [Related]
40. Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans.
Farooqui AA; Ong WY; Horrocks LA; Chen P; Farooqui T
Brain Res Rev; 2007 Dec; 56(2):443-71. PubMed ID: 17959252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
